Re-designing and Transforming PV for Augmenting Patient Safety

Share this

Re-designing and Transforming PV for Augmenting Patient Safety

The 10th Anniversary of the Pharmacovigilance Conference organized by DIA will be held from 25-26th May 2023 at Radisson Blu International Airport, Mumbai. The featured exhibitors for the conference are Parexel, Syneos Health, and Labcorp.

The conference will bring to you key speakers across the industry sharing insights on the changing PV landscape, expanding the vistas of drug safety enhancement of healthcare, outcomes, and treatment efficacy ushering in safe personalized medicines through advanced healthcare science.

Registration Link:  https://bit.ly/3n3UMYO

Promotional/Referral Code: PVPHARMA23

The focus is to create insightful sessions among all stakeholders around the following themes:

  • Current Regulatory challenges in the medical devices (MaterioVigilance) domain & solutions
  • Platform augment with AI/ML in streamlining the PV landscape
  • Personalised medical care, and ensuring Patients’ safety through Pharmacogenomics
  • Cosmetovigilance: Cosmetic testing roadmap to Cosmetovigilance
  • Patient-centricity and patient-centric health systems
  • Adoption of Decentralised Clinical Trials (DCT) Management, the challenges involved & pragmatic approaches
  • Excellence in Medical Writing through integrated and synchronized teamwork between Pharmacovigilance, Regulatory Affairs & Medical Affairs

The learning objectives from the sessions will be:

  • Pharmacogenomics: The Cornerstone of Personalized Medicine
  • Medical Writing & Pharmacovigilance: Leveraging the synergies for benefiting patients
  • Science of Literature Surveillance & Technology Roadmap
  • Changing Landscape of Materiovigilance
  • PV and Covid, Expectations vs Reality
  • New Age Pharmacovigilance- New and Emerging Therapies and Our Readiness
  • PV system for improved patient safety enabled by platforms, Artificial Intelligence and Automation
  • Cosmetology

The keynote speakers of the event are:

  • Moin Don, Adjunct Prof Jamia Hamdard Delhi, Lead: South Asia Chapter (ISoP), International Society of Pharmacovigilance (ISoP), Founder & CEO PVCON Consulting, India
  • Ashish Indani, Sr. Manager – Clinical Affairs, Stryker , India
  • Fahd Khan, Director Business Development, OrciMed Life Science Private Limited, India
  • Prashant Joshi, RPh, Executive Director - Drug Safety, Labcorp Drug Development, India
  • Ritu Jaswal, Vice President- Pharmacovigilance Operations, PAREXEL, India
  • Saket Singh Kumar, MSc, VP Global PV Capability Lead, Accenture , India
  • Sonica Sachdeva Batra, DrMed, Associate Vice President, Global Delivery Head, Indegene, India
  • J Vijay Venkatraman, MD, MBA, Managing Director and CEO, Oviya MedSafe, India
  • Vijay Bhargav, Vice President, Lifecycle Safety, IQVIA, India
  • Shobhit Shrotriya, PMP, Managing Director, Life Sciences R&D Operations, Accenture, India
  • Abhijit Surwade, Global Pharmacovigilance Physician, Colgate-Palmolive, India
  • Gerald J. Dal Pan, MD, MHS, Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
  • Prashant Dhanavade, Associate Director - Patient Safety Solutions, Labcorp Drug Development, India
  • Brian Edwards, DrMed, Vice President, International Society of Pharmacovigilance, United Kingdom
  • Jeyaseelan Jeyaraj, Senior Director, Solutions Consulting, Asia Pacific, Oracle Health Sciences Global Business Unit, India
  • Kedar Mehta, Associate Professor, Govt. Medical College Vadodara, India
  • Sakshi Rastogi, Global Client Solutions Partner, Quantiphi, India
  • Srikanth S, MPharm, Associate Director, Head - SARA Literature center, Life Cycle Safety, IQVIA, India
  • Arunima Sen, MD, Associate Vice President, Product Safety and Risk Management, Viatris, India
  • Renu Sharma, Senior Director Pharmacovigilance Operations, Parexel, India
  • Mohammed Sibgatullah, Director -Medical Affairs, OrciMed Life Science Private Limited, India
  • Niraj Vyas, Director of Risk Management & Central Monitoring, The Janssen Pharmaceutical Companies of Johnson & Johnson, India
  • Anu Acharya, CEO, Mapmygenome.in, India
  • Vaibhav Budhiraja, Senior Manager - PV Operations, Paraxel, India
  • Bobby George, Ph.D., Vice President & Group Head Regulatory Affairs, Reliance Life Sciences, India
  • Mukesh Gori, Director –CMO&IPS, Global External Service Partner Engagement,
  • Pharmacovigilance & Safety Alliance Operations, Novartis, India
  • Sadhna Jitendra Joglekar, MD, Senior Vice President Global Medical Affairs, Novartis, India
  • V. Kalaiselvan, Senior Principal Scientific Officer, Indian Pharmacopoeia Commission, India
  • Shadab Makhdoomi, Associate Vice President, Accenture Life Sciences, India
  • Pravin Patil, Manger, PRMW, Global Pharmacovigilance, Innovation & Development Established, Pharmaceuticals, Abbott Healthcare Pvt Ltd, India
  • Geethashree Shambu, Delivery Lead - Safety Operations, Indegene Pvt Ltd, India
  • Thirumalai Velu Swaminathan, Director, India & South Asia-Regulatory Affairs & Pharmacovigilance, Galderma India Pvt Limited, India
  • Sanjay Vyas, Executive Vice President, India Country Head & Managing Director, Global SBU, Head - Safety Services & Logistics, Parexel, India
  • Jamal Anwar Baig, Ph.D., Multi-Country Safety Head – South Asia & Indo-China (Vietnam), Sanofi, India
  • Naveen Chhabra, Global Medical Safety Lead, Global Drug Development, Novartis, India
  • Varun Dua, Vice President -Professional Services, RxLogix, India
  • Dhanaraj E, Pharmacovigilance Lead- CDMA-BBL, Biocon, India
  • Kanchan Kanitkar, Sr. Manager and Literature SME - Patient Safety Solution, Labcorp Drug Development India Pvt Ltd. India
  • Ram Mudaliar, Senior Director (India CDI Lead) Clinical Data & Insights (CDI), AstraZeneca, India
  • John Praveen, Associate Vice President – PV Account Delivery and PV Shared Services Offering, Lead, Accenture, India
  • Shubha Rao, DDS, MSc, Senior Director, Pharmacovigilance and Drug Safety, Indegene Pvt Ltd, India
  • Omprakash Sadhwani, Joint Commissioner (Law), FDA, India
  • Viqar Ahmed Shah, Senior Manager - Regulatory Affairs, Mylab Discovery Solutions Pvt. Ltd., India
  • Chetanraj Bhamare, Safety Physician (Asst. General Manager), Clinical Research, and pharmacovigilance dept., Serum Institute of India Pvt Ltd, India
  • Pankajkumar Chhatrala, Founder, CEO, Orthoheal, India
  • Susan Korah, AVP, TCS, India
  • Bindu Narang, Executive Director - Patient Safety Solutions, Labcorp, India
  • Shatrunajay Shukla, Scientific Assistant MvPI, Indian Pharmacopoeia Commission, India
  • Tarunjot Singh, DDS, Director - Safety and Pharmacovigilance, Syneos Health, India

The two days conference will bring together attendees from different various domains including Pharmacovigilance and Drug Safety, Risk Management, Clinical Professionals, Medical Writing, Pharmacovigilance Compliance, Regulatory Affairs, Medical Affairs

Late Phase Professionals Conducting PMS, Observational and Non-Interventional Studies, Real World Data and Real-World Evidence, and Technology Professionals. So come and expand your knowledge of the drug safety enhancement of healthcare and strategies at this top-level conference.


Related Post: Exclusive Coverage: Key Takeaways from the DIA India Medical Devices Conference 2020

Senior Editor

Senior Editor at PharmaShots. She is curious and very passionate about recent updates and developments in the life sciences industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions